요로감염증 검사 시장 규모, 점유율, 성장 분석 : 검사 키트별, 감염증 유형별, 검사 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Urinary Tract Infection Testing Market size was valued at USD 638.27 Million in 2024 and is poised to grow from USD 667.63 Million in 2025 to USD 956.73 Million by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

The global urinary tract infection (UTI) testing market is experiencing significant growth, driven by advancements in diagnostic technologies and heightened awareness of UTIs, which predominantly affect women. Key factors fueling this market include the increasing incidence of UTIs, rising healthcare expenditures, and an aging population that is more vulnerable to such infections. Innovations in technology are yielding more accurate and efficient diagnostic tools, such as point-of-care tests and non-invasive techniques, facilitating better detection and management of UTIs. Additionally, the trend towards personalized healthcare encourages providers to embrace advanced diagnostic solutions, further increasing demand. Nevertheless, challenges related to the accuracy of certain testing methods and alternative treatment options may pose constraints on market expansion, despite a general focus on infection management within the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segments Analysis

Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinary Tract Infection Testing Market

The global market for urinary tract infection testing is largely propelled by the rising incidence of antibiotic-resistant UTIs. The inappropriate use of antibiotics has resulted in the development of resistant bacterial strains, making UTI management increasingly complex. This critical issue has created a demand for precise diagnostic methods, including urine cultures and susceptibility testing, which allow healthcare professionals to determine the most effective treatment options based on the specific bacteria involved. Furthermore, the pressing need to address antibiotic resistance has stimulated investment in research and development for new therapies, guiding the market towards innovative solutions that tackle resistant UTIs while encouraging responsible antibiotic usage.

Restraints in the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market faces notable challenges due to antibiotic resistance. The inappropriate use and over-prescription of antibiotics have resulted in the rise of drug-resistant bacteria, diminishing the efficacy of traditional treatments for UTIs. This ongoing issue complicates the treatment landscape, leading to prolonged infections, heightened medical expenses, and the potential for serious complications. Healthcare professionals are required to carefully manage the use of antibiotics, ensuring effective treatment while promoting responsible prescribing practices. As a result, there is an increasing demand for innovative therapeutic solutions and advanced diagnostic methods to address this critical public health challenge.

Market Trends of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is witnessing a significant shift towards the adoption of Point-of-Care (POC) testing solutions, driven by the need for rapid and efficient diagnostics. These POC methods enable healthcare providers to deliver immediate results at the site of care, bypassing traditional laboratory processes and significantly shortening turnaround times. This trend is particularly beneficial in primary care environments where quick diagnosis is crucial for effective treatment. Enhanced accuracy and efficiency of POC technologies are empowering healthcare professionals to make informed decisions swiftly, thereby improving patient outcomes and optimizing healthcare resources. As these innovations proliferate, they are fundamentally redefining UTI diagnostic practices worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2026-2033)

• Market Overview
• Home Test Kits
• Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2026-2033)

• Market Overview
• Urethritis
• Cystitis
• Pyelonephritis

Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Urinalysis
• Urine Cultures
• Susceptibility Testing

Global Urinary Tract Infection Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• General Practitioners (GPs)
• Urologists
• Urogynecologists
• Hospital Laboratories
• Reference Laboratories
• Hospital Emergency Departments
• Urgent Care
• Others

Global Urinary Tract Infection Testing Market Size & CAGR (2026-2033)

• North America (Test Kit, Infection Type, Test Type, End User)
  • US
  • Canada
• Europe (Test Kit, Infection Type, Test Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Kit, Infection Type, Test Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Kit, Infection Type, Test Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesa Biotech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA) (Parent Company: Abbott Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations